Immunological Comparison of AIT and SCIT Immunotherapy Against Grass Pollen
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
Treatment of pollen allergies can be roughly divided into symptomatic treatment (e.g.
antihistamines, steroids) and potentially curative immunotherapy. Immunotherapy can be
delivered using subcutaneous or oral (mucosal) routes, with similar clinical outcome. The
study seeks to compare immunological changes during subcutaneous (SCIT) and sublingual tablet
(AIT) immunotherapy of grass pollen allergy (hayfever).